ProShare Advisors
SVRA icon

ProShare Advisors’s Savara SVRA Stock Holding History

ProShare Advisors’s Portfolio SVRA Stock Details SVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$165K Sell
26,753
-3,589
-12% -$19.3K ﹤0.01% 1686
2026
Q1 		$166K Sell
30,342
-4,527
-13% -$25.2K ﹤0.01% 1631
2025
Q4 		$210K Buy
34,869
+9,133
+35% +$44.7K ﹤0.01% 1687
2025
Q3 		$91.9K Sell
25,736
-6,662
-21% -$19.7K ﹤0.01% 1856
2025
Q2 		$73.9K Sell
32,398
-1,417
-4% -$3.85K ﹤0.01% 1930
2025
Q1 		$93.7K Sell
33,815
-6,812
-17% -$18.8K ﹤0.01% 1845
2024
Q4 		$125K Buy
40,627
+9,096
+29% +$31.7K ﹤0.01% 2025
2024
Q3 		$134K Buy
31,531
+10,901
+53% +$48.1K ﹤0.01% 1834
2024
Q2 		$83.1K Sell
20,630
-5,085
-20% -$22.6K ﹤0.01% 1689
2024
Q1 		$128K Buy
25,715
+2,114
+9% +$10.2K ﹤0.01% 1782
2023
Q4 		$111K Buy
23,601
+11,865
+101% +$45.5K ﹤0.01% 1767
2023
Q3 		$44.4K Buy
+11,736
New +$41.8K ﹤0.01% 1726
2021
Q2 		– Sell
-12,833
Closed -$27K – 2400
2021
Q1 		$27K Buy
12,833
+2,164
+20% +$3.7K ﹤0.01% 2254
2020
Q4 		$12K Buy
+10,669
New +$12.9K ﹤0.01% 2093
2019
Q4 		– Sell
-15,106
Closed -$40K – 1799
2019
Q3 		$40K Buy
15,106
+1,042
+7% +$2.6K ﹤0.01% 1612
2019
Q2 		$33K Sell
14,064
-984
-7% -$8.74K ﹤0.01% 1593
2019
Q1 		$111K Buy
15,048
+122
+0.8% +$919 ﹤0.01% 1562
2018
Q4 		$113K Sell
14,926
-2,890
-16% -$26K ﹤0.01% 1459
2018
Q3 		$199K Buy
17,816
+1,662
+10% +$19.1K ﹤0.01% 1605
2018
Q2 		$183K Buy
16,154
+2,052
+15% +$20.6K ﹤0.01% 1630
2018
Q1 		$130K Sell
14,102
-2,331
-14% -$27.4K ﹤0.01% 1611
2017
Q4 		$244K Buy
+16,433
New +$188K ﹤0.01% 1531

Other funds holding SVRA

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

ProShare Advisors's SVRA Position: Q2 2026 in Review

ProShare Advisors reduced its Savara (SVRA) stake by 12% in Q2 2026, selling an estimated $19.3K and leaving 26,753 shares worth $165K. The position accounts for ﹤0.01% of the portfolio, ranked #1686.

ProShare Advisors first reported a position in SVRA in Q4 2017 and has held it in 22 quarters since. The position peaked at $244K in Q4 2017. 181 funds tracked by Wall St. Rank hold SVRA as of Q2 2026.

  • ProShare Advisors held 26,753 shares of Savara worth $165K as of Q2 2026.
  • ProShare Advisors sold 3,589 Savara shares in Q2 2026, an estimated $19.3K.
  • Savara made up ﹤0.01% of ProShare Advisors's portfolio in Q2 2026, its #1686 holding.
  • ProShare Advisors first reported a position in Savara in Q4 2017 and has held it in 22 quarters since.
  • ProShare Advisors's Savara position peaked at $244K in Q4 2017.
  • 181 funds tracked by Wall St. Rank held Savara as of Q2 2026.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.